Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
STERIS plc
Bear Case (25th pct.)
-36.0% vs price
Base Case (Median)
-26.2% vs price
Bull Case (75th pct.)
-13.1% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $151.35 | -26.2% | High (40%) |
| PE Comparable | $183.57 | -10.5% | Medium (25%) |
| Growth Trajectory DCF | $252.30 | 23.0% | Medium (20%) |
| Graham Number | $116.39 | -43.2% | Medium (40%) |
| EV/EBITDA | $146.20 | -28.7% | Medium (20%) |
| EV/FCF | $172.79 | -15.7% | Medium (20%) |
| Earnings Power Value | $86.22 | -58.0% | Medium (50%) |
Based on 7 out of 7 methods, STE appears overvalued at the current price of $205.04. The base case fair value of $151.35 implies 26.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.